State Street
DTIL icon

State Street’s Precision BioSciences DTIL Stock Holding History

State Street’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Buy
72,942
+13,900
+24% +$64.1K ﹤0.01% 3712
2025
Q4 		$246K Buy
59,042
+20,900
+55% +$119K ﹤0.01% 3852
2025
Q3 		$211K Buy
38,142
+11,900
+45% +$57K ﹤0.01% 3900
2025
Q2 		$110K Buy
26,242
+4,200
+19% +$20.7K ﹤0.01% 3960
2025
Q1 		$105K Hold
22,042
– – ﹤0.01% 3969
2024
Q4 		$84K Buy
22,042
+10,800
+96% +$78.9K ﹤0.01% 4026
2024
Q3 		$101K Hold
11,242
– – ﹤0.01% 3974
2024
Q2 		$109K Buy
+11,242
New +$132K ﹤0.01% 3987
2024
Q1 		– Sell
-8,145
Closed -$89.2K – 4376
2023
Q4 		$89.2K Hold
8,145
– – ﹤0.01% 4074
2023
Q3 		$83.4K Hold
8,145
– – ﹤0.01% 4153
2023
Q2 		$129K Hold
8,145
– – ﹤0.01% 4144
2023
Q1 		$184K Buy
8,145
+750
+10% +$24.7K ﹤0.01% 4105
2022
Q4 		$264K Buy
7,395
+1,857
+34% +$73.4K ﹤0.01% 4005
2022
Q3 		$216K Hold
5,538
– – ﹤0.01% 4104
2022
Q2 		$266K Sell
5,538
-36,322
-87% -$2.13M ﹤0.01% 4084
2022
Q1 		$3.87M Sell
41,860
-52,097
-55% -$7.08M ﹤0.01% 3305
2021
Q4 		$20.9M Buy
93,957
+9,502
+11% +$2.65M ﹤0.01% 2451
2021
Q3 		$29.2M Sell
84,455
-8,427
-9% -$2.86M ﹤0.01% 2200
2021
Q2 		$34.9M Sell
92,882
-78,743
-46% -$23.7M ﹤0.01% 2115
2021
Q1 		$53.3M Buy
171,625
+85,428
+99% +$29.9M ﹤0.01% 1703
2020
Q4 		$21.6M Buy
86,197
+60,452
+235% +$14.8M ﹤0.01% 2202
2020
Q3 		$4.76M Buy
25,745
+335
+1% +$66.6K ﹤0.01% 2814
2020
Q2 		$6.35M Buy
25,410
+5,335
+27% +$1.17M ﹤0.01% 2643
2020
Q1 		$3.63M Buy
20,075
+1,587
+9% +$415K ﹤0.01% 2783
2019
Q4 		$7.7M Buy
18,488
+13,737
+289% +$4.32M ﹤0.01% 2651
2019
Q3 		$1.2M Buy
4,751
+79
+2% +$25.7K ﹤0.01% 3367
2019
Q2 		$1.34M Buy
+4,672
New +$1.88M ﹤0.01% 3368

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street's DTIL Position: Q1 2026 in Review

State Street increased its Precision BioSciences (DTIL) stake by 24% in Q1 2026, buying an estimated $64.1K and bringing the position to 72,942 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

State Street first reported a position in DTIL in Q2 2019 and has held it in 27 quarters since. The position peaked at $53.3M in Q1 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • State Street held 72,942 shares of Precision BioSciences worth $401K as of Q1 2026.
  • State Street bought 13,900 Precision BioSciences shares in Q1 2026, an estimated $64.1K.
  • Precision BioSciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3712 holding.
  • State Street first reported a position in Precision BioSciences in Q2 2019 and has held it in 27 quarters since.
  • State Street's Precision BioSciences position peaked at $53.3M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.